Brain metastases
- PMID: 10333375
- DOI: 10.1016/s0147-0272(99)90007-7
Brain metastases
Abstract
The topic of brain metastases has recently become a popular subject for review. The reasons for this most likely include technical advances in therapy, notably radiosurgery, as well as recently-published reports of phase III studies, which have addressed certain aspects of management, notably the combination of surgery and radiotherapy in the treatment of patients with a single metastasis. The main purpose of treatment is to reverse the patient's neurological deficits and prolong life. Nevertheless, opinions remain divided on whether meaningful clinical progress has been achieved overall. A clinician working in a tertiary referral center offering radiosurgery for a selected group of favorable patients may believe that the therapeutic nihilism of the past is no longer warranted, whereas another, whose experience is based on the management of patients dying from metastatic lung cancer, may still question the value of active treatment. The purpose of this review will be to try to reconcile these opinions by providing a critical analysis of the available evidence, identify current problems in management, and suggest future directions for clinical investigation.
Similar articles
-
The evolving clinical management of cerebral metastases.Eur J Surg Oncol. 2017 Jul;43(7):1173-1185. doi: 10.1016/j.ejso.2016.10.006. Epub 2016 Oct 27. Eur J Surg Oncol. 2017. PMID: 27986364 Review.
-
[Guidelines for the diagnosis and management of brain metastases].Medicina (Kaunas). 2003;39(8):804-11. Medicina (Kaunas). 2003. PMID: 12960461 Review. Lithuanian.
-
Brain metastases: treatment options to improve outcomes.CNS Drugs. 2002;16(5):325-38. doi: 10.2165/00023210-200216050-00005. CNS Drugs. 2002. PMID: 11994022 Review.
-
Diagnosis and management of brain metastases.Hematol Oncol Clin North Am. 2001 Dec;15(6):1085-107, vii. doi: 10.1016/s0889-8588(05)70269-0. Hematol Oncol Clin North Am. 2001. PMID: 11770300 Review.
-
Metastases to the brain: current management perspectives.Expert Rev Neurother. 2004 Jul;4(4):633-40. doi: 10.1586/14737175.4.4.633. Expert Rev Neurother. 2004. PMID: 15853582 Review.
Cited by
-
Rare incidence of a diffuse brain metastatic carcinoma: A case report.Oncol Lett. 2014 Oct;8(4):1807-1809. doi: 10.3892/ol.2014.2377. Epub 2014 Jul 24. Oncol Lett. 2014. PMID: 25202414 Free PMC article.
-
Brain metastases.Curr Treat Options Oncol. 2000 Dec;1(5):447-58. doi: 10.1007/s11864-000-0072-3. Curr Treat Options Oncol. 2000. PMID: 12057152 Review.
-
Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.Neurosurg Rev. 2005 Apr;28(2):115-9. doi: 10.1007/s10143-004-0364-3. Epub 2004 Dec 18. Neurosurg Rev. 2005. PMID: 15609059
-
Lung cancer: district active treatment rates affect survival.J Epidemiol Community Health. 2002 Jun;56(6):424-9. doi: 10.1136/jech.56.6.424. J Epidemiol Community Health. 2002. PMID: 12011196 Free PMC article.
-
Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.Cancer Res. 2008 Dec 1;68(23):9634-42. doi: 10.1158/0008-5472.CAN-08-1429. Cancer Res. 2008. PMID: 19047140 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous